Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

Université Laval

$59,800.00

Advanced materials and processes for a new class of degradable coronary stents

EF 2008-09

Résumé
Implantation of medical devices made of metallic, polymeric and ceramic materials saves lives and improves quality of life for millions of people around the globe. Coronary stents are just an example of these devices, and they have been proven effective in treating coronary and peripheral arterial occlusions. They are currently implanted on a long-term (permanent) basis, and therefore made of corrosion-resistant alloys, such as (mainly) stainless steel or nickel-titanium. However, clinical complications such as restenosis and thrombosis have often been reported. To reduce the risk of thrombus formation and restenosis, clinicians are looking for a new class of degradable stents, since the narrowed artery only requires a stent for a limited period of up to one year. Therefore, advanced materials and processes have to be investigated in order to allow the development of this new class of stents. The general objective of this research project will be to study the clinical potential that Mg- and Fe-based alloys with tailored micro-structural properties represent toward the design of a new class of degradable endovascular stents. These stents will first support the narrowed, atherosclerotic vessel wall for the first six months after implantation, then slowly degrade to completely disappear after one year of implantation. To reach this goal, we propose to study the mechanisms leading to the degradation of the specimens in vitro (hemocompatibility) and in vivo, when implanted in rabbits for periods up to 18 months, and to complete degradation. Stented arteries will also be evaluated with 2D echo imaging and Doppler flow velocity in order to verify thrombotic occlusion or stenosis. Microscopic evaluation of the vessel wall will be performed to characterize the consequences of the implantation of the stent at a cellular level (inflammation, fibrotic changes). In vitro testing of the endothelial function of the vessel sections will be also performed by exposing the rings to vaso-active agents. Portions of the stented aortas will be preserved for tissue analysis and evaluation of the endothelial lining, fibrosis, inflammatory cell infiltration and atherosclerotic lesions.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
323482-2006
Name nom
Mantovani, Diego
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2006
Award amount
59800
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2000
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials science and technology
Research subject fr
Science et technologie des matériaux
Partie
3
Nb partie
3
Application title
Advanced materials and processes for a new class of degradable coronary stents
Keyword
NA
Application summary
Implantation of medical devices made of metallic, polymeric and ceramic materials saves lives and improves quality of life for millions of people around the globe. Coronary stents are just an example of these devices, and they have been proven effective in treating coronary and peripheral arterial occlusions. They are currently implanted on a long-term (permanent) basis, and therefore made of corrosion-resistant alloys, such as (mainly) stainless steel or nickel-titanium. However, clinical complications such as restenosis and thrombosis have often been reported. To reduce the risk of thrombus formation and restenosis, clinicians are looking for a new class of degradable stents, since the narrowed artery only requires a stent for a limited period of up to one year. Therefore, advanced materials and processes have to be investigated in order to allow the development of this new class of stents. The general objective of this research project will be to study the clinical potential that Mg- and Fe-based alloys with tailored micro-structural properties represent toward the design of a new class of degradable endovascular stents. These stents will first support the narrowed, atherosclerotic vessel wall for the first six months after implantation, then slowly degrade to completely disappear after one year of implantation. To reach this goal, we propose to study the mechanisms leading to the degradation of the specimens in vitro (hemocompatibility) and in vivo, when implanted in rabbits for periods up to 18 months, and to complete degradation. Stented arteries will also be evaluated with 2D echo imaging and Doppler flow velocity in order to verify thrombotic occlusion or stenosis. Microscopic evaluation of the vessel wall will be performed to characterize the consequences of the implantation of the stent at a cellular level (inflammation, fibrotic changes). In vitro testing of the endothelial function of the vessel sections will be also performed by exposing the rings to vaso-active agents. Portions of the stented aortas will be preserved for tissue analysis and evaluation of the endothelial lining, fibrosis, inflammatory cell infiltration and atherosclerotic lesions.